Cigna's Coverage Criteria for Poteligeo (mogamulizumab-kpkc) in Illinois: What Counts as "Medically Necessary"?
Answer Box: Getting Poteligeo Covered by Cigna in Illinois
Cigna requires prior authorization for Poteligeo (mogamulizumab-kpkc) with three key criteria: (1) confirmed mycosis fungoides or Sézary syndrome with TNMB staging, (2) failure of at least one prior systemic therapy, and (3) prescription by an oncologist or dermatologist. First step today: